台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    73.4
  • 漲跌
    ▲6.6
  • 漲幅
    +9.88%
  • 成交量
    332
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-元大-新竹經國 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1202/2403/1803/2804/1003/0660708090100110120May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元大-新竹經國 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/09067.00067.1066.8002,3770.00%
2025/04/0200.00487.5087.90-42,294-0.17%
2025/04/0100.00689.2090.10-62,285-0.26%
2025/03/31089.90088.5088.0002,2770.00%
2025/03/283095.4200.0093.80302,2571.33%
2025/03/27495.5000.0096.1042,2480.18%
2025/03/25198.80298.2598.60-12,210-0.05%
2025/03/24199.40199.0099.0002,1920.00%
2025/03/21196.6000.0096.4012,1490.05%
2025/03/1400.00692.2092.50-62,087-0.29%
2025/03/131.497.1900.0091.601.42,0990.07%
2025/03/11196.00196.6095.6002,0410.00%
2025/03/06396.7300.0094.3031,9570.15%
2025/03/0500.00597.4098.60-51,924-0.26%
2025/03/03593.9000.0094.2051,8870.26%
2025/02/241102.50199.4099.3001,7960.00%
2025/02/215104.0000.0098.9051,7270.29%
2025/02/20199.50196.0099.7001,5530.00%
2025/02/1800.00695.0794.00-61,491-0.40%
2025/02/172108.2511.298.6597.10-9.21,440-0.64%
2025/02/140.298.7000.0098.900.21,2260.02%
2025/02/07190.0000.0090.1011,1250.09%
2025/02/04283.90183.9083.3011,1140.09%
2025/01/200.283.2000.0084.200.21,1360.02%
2025/01/170.284.7000.0084.600.21,1310.02%
2025/01/150.486.0000.0086.200.41,1570.03%
2025/01/100.288.3000.0090.500.21,0640.02%
2025/01/090.288.30988.6187.50-8.81,014-0.87%
2025/01/082100.250.2101.1897.201.88720.21%
2025/01/07792.6700.0092.7076491.08%
2025/01/0300.00488.2588.30-4600-0.67%
2024/12/23183.0000.0082.9016120.16%
2024/12/2000.00282.2082.10-2613-0.33%
2024/12/18182.5000.0082.9016260.16%
2024/12/11386.501085.8086.00-7621-1.13%
2024/12/1000.006.587.9987.50-6.5615-1.05%
2024/12/091.588.60490.3090.10-2.5600-0.42%
2024/12/061188.83588.9087.6065731.05%
2024/12/0400.00585.3085.30-5529-0.95%
2024/12/02584.30585.3084.2005240.00%
2024/11/29584.2000.0084.3055240.95%
2024/11/28582.0000.0082.0055340.93%
2024/11/26184.0000.0083.9015390.19%
2024/11/25384.9300.0085.0035430.55%
2024/11/08180.4000.0080.1015220.19%
2024/11/04182.00181.8081.6005790.00%
2024/11/0100.00182.7082.80-1606-0.16%
2024/10/301583.131482.5981.4016010.17%
2024/10/29180.40180.4080.9005880.00%
2024/10/28184.60182.2081.0005840.00%
2024/10/25281.7000.0081.4025670.35%
2024/10/24382.20380.8780.8005720.00%
2024/10/23180.7000.0081.8015700.18%
2024/10/141074.5000.0074.00106141.63%
2024/09/0300.00184.5084.00-1751-0.13%
2024/08/30286.30486.8386.40-2750-0.27%
2024/08/2800.00283.8083.70-2733-0.27%
2024/08/2200.00181.4081.30-1759-0.13%
2024/08/2100.00680.9380.90-6760-0.79%
2024/08/1600.00380.2080.90-3753-0.40%
2024/08/15280.20280.0080.0007750.00%
2024/08/14678.3700.0079.5067750.77%
2024/08/0900.00178.5078.40-1785-0.13%
2024/08/080.175.0000.0076.700.17830.01%
2024/08/07174.20175.2075.6007790.00%
2024/08/06270.1000.0070.3027710.26%
2024/08/05174.4000.0074.0017340.14%
2024/08/0200.00183.5082.20-1708-0.14%
2024/07/310.483.0000.0082.600.47320.05%
2024/07/2300.00187.0086.50-1746-0.13%
2024/07/22187.8000.0087.1017450.13%
2024/07/19187.8000.0086.5017270.14%
2024/07/15286.3000.0086.3027470.27%
2024/07/0500.00287.1086.80-2856-0.23%
2024/06/2800.001090.1089.30-101,103-0.91%
2024/06/26288.6000.0089.5021,1230.18%
2024/06/251087.6000.0087.80101,1210.89%
2024/06/21188.5000.0088.9011,1210.09%
2024/06/1200.00591.8091.00-51,174-0.43%
2024/06/11590.601292.2191.00-71,182-0.59%
2024/06/07589.7000.0090.1051,1670.43%
2024/06/05390.3000.0090.3031,2370.24%
2024/05/3100.00289.4090.10-21,420-0.14%
2024/05/29491.2000.0089.1041,5110.26%
2024/05/2300.00187.9087.10-12,014-0.05%
2024/05/2200.000.488.3088.50-0.42,100-0.02%
2024/05/21190.10189.0988.0002,1230.00%
2024/05/20187.1000.0087.2012,1300.05%
2024/05/1400.00187.8087.40-12,250-0.04%
2024/05/09086.1000.0085.7002,3370.00%
2024/05/0800.00786.0086.70-72,335-0.30%
2024/05/06287.0000.0088.0022,3310.09%
2024/05/0300.00385.6385.80-32,318-0.13%
2024/04/30185.4000.0085.5012,3290.04%
2024/04/25082.9000.0082.5002,3250.00%
2024/04/24584.0000.0084.8052,3210.22%
2024/04/230.282.8000.0082.800.22,3280.01%
2024/04/221.482.4200.0081.801.42,3290.06%
2024/04/1900.000.184.0083.10-0.12,3340.00%
2024/04/18287.45586.9686.80-32,357-0.13%
2024/04/174.188.7000.0087.804.12,3560.17%
2024/04/1600.00289.4087.90-22,351-0.09%
2024/04/15290.208.691.9590.10-6.62,342-0.28%
2024/04/12495.68394.0094.0012,3390.04%
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-1天前
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-15天前
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕 相關文章